US Stock MarketDetailed Quotes

KRRO Korro Bio

Watchlist
  • 43.670
  • +0.550+1.28%
Close Dec 20 16:00 ET
  • 43.670
  • 0.0000.00%
Post 16:13 ET
409.11MMarket Cap-4.31P/E (TTM)

About Korro Bio Company

Korro Bio, Inc. is an RNA editing company, which engages in the discovery and development of genetic medicines. The company was founded by Nessan Bermingham, Jean-Francois Formela, Joshua Rosenthal, and Andrew Fraley in 2018 and is headquartered in Cambridge, MA.

Company Profile

SymbolKRRO
Company NameKorro Bio
Listing DateOct 3, 2019
Founded2018
CEODr. Ram Aiyar, M.B.A.,PhD
MarketNASDAQ
Employees102
Fiscal Year Ends12-31
Address60 First Street,2nd floor,Suite 250
CityCambridge
ProvinceMassachusetts
CountryUnited States of America
Zip Code02141
Phone1-617-468-1999
Websitehttp://www.korrobio.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Ram Aiyar, M.B.A.,PhD
  • Director, President and Chief Executive Officer
  • --
  • Christopher R. Loose, PhD
  • Chief Scientific Officer
  • --
  • Todd Chappell, M.B.A.
  • Chief Operating Officer
  • --
  • Vineet Agarwal, M.B.A.
  • Chief Financial Officer and Principal Accounting Officer
  • --
  • Shelby J. Walker, J.D.,M.S.
  • Senior Vice President, General Counsel and Corporate Secretary
  • --
  • Dr. Nessan Bermingham, PhD
  • Chairman of the Board
  • --
  • Rachel Meyers
  • Director
  • --
  • Dr. Katharine Knobil, M.D.
  • Director
  • --
  • Dr. Ali Behbahani, M.B.A.,M.D.
  • Independent Director
  • --
  • Timothy R. Pearson
  • Independent Director
  • --
  • Dr. Jean-Francois Formela,M.D.
  • Independent Director
  • --
Heat List
US
Overall
Symbol
Price
% Chg

No Data